The Manas AI co-founder said at the Hindustan Times Leadership Summit 2026 that clinical trials and regulatory delays still drive up costs, urging India to streamline testing rules to reverse rising drug development expenses.
The Manas AI co-founder said at the Hindustan Times Leadership Summit 2026 that clinical trials and regulatory delays still drive up costs, urging India to streamline testing rules to reverse rising drug development expenses.
<iframe src="https://hindustansphere.com/embed/cluster/d2799c00a9f28e7f74042f560eaa5b2f5cc9b3da" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="AI cuts early cancer drug discovery from 8 years to 3 months: Dr Siddhartha Mukherjee"></iframe>
The Manas AI co-founder said at the Hindustan Times Leadership Summit 2026 that clinical trials and regulatory delays still drive up costs, urging India to streamline testing rules to reverse rising drug development expenses.
